Open search

Search suggestion

Open suggestion box

Search suggestion

See related products

Kluwer Patent Blog

Search filters

Clear all

GENERAL PREFERENCES

Sort by

Search

Search only titles

Jurisdiction

Germany (331)

France (0)

Poland (0)

Netherlands (0)

Bulgaria (0)

United Kingdom (0)

Spain (0)

Denmark (0)

Belgium (0)

European Union (0)

Italy (0)

Austria (0)

United States of America (0)

Estonia (0)

Greece (0)

Switzerland (0)

Sweden (0)

Norway (0)

Slovenia (0)

Lithuania (0)

Czech Republic (0)

Hungary (0)

Finland (0)

China (0)

Australia (0)

Portugal (0)

Latvia (0)

India (0)

Russia (0)

Ireland (0)

Ukraine (0)

Turkey (0)

Brazil (0)

South Africa (0)

Japan (0)

Canada (0)

Mexico (0)

New Zealand (0)

Argentina (0)

Saudi Arabia (0)

Singapore (0)

EPC (0)

Tags

European Patent Litigation (7)

European Union (7)

Unitary Patent (7)

Germany (6)

Brexit (5)

infringement (5)

nullity action (5)

UPC (5)

claim construction (4)

SPC (3)

UPCA ratification (3)

Validity (3)

doctrine of equivalence (2)

EPO organisation unconstitutional (2)

escitalopram (2)

Lundbeck (2)

Marketing authorization (2)

patent (2)

PI (2)

trade show (2)

UPCA (2)

Added Matter (1)

AIDS (1)

algorithm (1)

amendments (1)

back reference (1)

BGH (1)

BGH X ZU 36/13 (1)

bifurcation (1)

Case Law (1)

CJEU (1)

Clarity (1)

Community Design (1)

compulsory license (1)

constitutional complaint (1)

cooking pan (1)

Covid-19 (1)

Daimler AG (1)

data (1)

Diglycidverbindung (1)

doctrine of eqivalence (1)

doctrine of equivalanet (1)

drugs (1)

DVD (1)

encoding (1)

euqivalence (1)

exhaustion (1)

exhibition (1)

federal patent court (1)

firmware (1)

FRAND (1)

German Federal Patent Court (1)

guidelines (1)

Harnkatheterset (1)

Hetti Hilge (1)

HIV (1)

Improver (1)

inactivated feature (1)

Infringement; Declaratory Interest; NDA (1)

infringment action (1)

injunction (1)

inspection order (1)

intermediate generalization (1)

Inventive step (1)

Kochgefäß (1)

Kreiselegge II (1)

Mercedes-Benz (1)

Merck (1)

MPEG-2 (1)

Neurim (1)

Nokia (1)

nullity proceedings (1)

Okklusionsvorrichtung (1)

Patent Act (1)

patent infringement (1)

patentability (1)

patents (1)

Pemetrexed (1)

pharma patent (1)

pharmaceutical (1)

Pharmaceuticals (1)

Preliminary Injunction (1)

prior use right (1)

product directly obtained by a process (1)

proportionality defense (1)

Raffvorhang (1)

rospatt (1)

rospatt osten pross (1)

royalties (1)

royalty (1)

royalty rate (1)

Rule of Law (1)

same or similar act (1)

Santen (1)

Scope of protection (1)

separation (1)

SEPs (1)

Shinogi (1)

side-effect (1)

sleeping feature (1)

test purchase (1)

third party (1)

trade fair (1)

trademark (1)

training (1)

Transit proceedings (1)

Translation Requirement (1)

undisputed patent (1)

United Kingdom (1)

Value in Dispute (1)

video data (1)

X ZR 81/13 (1)

Zwangslizenz (1)

Doctrine of equivalents (0)

Patent prosecution estoppel (0)

Protocol of Interpreation of article 69 EPC (0)

burden of proof (0)

CPC (0)

Directive 2004/48 (0)

Imminent infringement (0)

TRIPS (0)

territorial jurisdiction (0)

Denmark (0)

equivalence (0)

luggage ramp (0)

SAS (0)

Bolar provision (0)

Mechanical Engineering (0)

Novelty (0)

settlement (0)

ex parte (0)

ratiopharm (0)

reversed burden of proof (0)

local jurisdictions (0)

Community Patent (0)

Harmonisation (0)

Multinational litigation (0)

Revocation (0)

divisionals (0)

EPO (0)

res iudicata (0)

International Judges Conference (0)

Art. 123(2) EPC (0)

Comprising-consisting (0)

interlocutory injunction (0)

marketing authorisation (0)

enforcement (0)

procedural matters (0)

Swiss Federal Patent Court (0)

costs (0)

supreme court (0)

Court of Justice of the European Union (0)

hESCs (0)

America Invents Act (0)

Patent Reform (0)

U.S. Patent Office (USPTO) (0)

infringment (0)

prosecution file (0)

20 Year Term (0)

Patent Term Adjustment (PTA) (0)

Wyeth (0)

CJEU; Medimmune; Novartis Pharmaceuticals (0)

America Invents Act (AIA) (0)

First To File (0)

Post Grant Review (0)

Secret Prior Art (0)

Discovery (0)

Evidence (0)

License (0)

Negotiations (0)

Privilege (0)

Reasonable Royalty (0)

ANDA (0)

Bayer (0)

Caraco (0)

Generic (0)

Hatch Waxman (0)

Orange Book (0)

Paragraph IV (0)

Prandin (0)

Repaglinide (0)

U.S. Supreme Court (0)

Yasmin (0)

utility models (0)

Obviousness Type Double Patenting (0)

Patent Term (0)

Terminal Disclaimer (0)

Myriad (0)

Personalized Medicine (0)

Prometheus (0)

litigation (0)

opposition (0)

Amphastar (0)

Enoxaparin (0)

FDA (0)

Lovenox (0)

Momenta (0)

Safe Harbor (0)

ACLU (0)

BRCA (0)

Breast Cancer (0)

Gene Patent (0)

Isolated DNA (0)

Applicant (0)

Inter Partes Review (0)

Inventor Oath/Declaration (0)

biotech (0)

sufficient disclosure (0)

Medeva Sanofi SPC injunction (0)

Preissuance Submissions (0)

Prior Art (0)

Protest (0)

Third-Party Submissions (0)

PCC (0)

Patent-Eligibility (0)

invalidity (0)

technical feature (0)

Jurisdiction (0)

Product Of Nature (0)

35 USC 101 (0)

Abstract Idea (0)

Alice Corporation (0)

CLS Bank (0)

human embryonic stem cells (0)

Non Practicing Entities (0)

Non Practicing Entity (0)

Patent Assertion Entities (0)

Patent Assertion Entity (0)

Patent Trolls (0)

White House (0)

Baxter (0)

Covered Business Method (0)

Fresenius (0)

Reexamination (0)

SAP (0)

Versata (0)

Patent Tertm Adjustment (0)

1977 UK Patents Act (0)

microcontroller (0)

smart card (0)

telecommunications (0)

referendum (0)

Innovation Act (0)

Goodlatte Innovation Act (0)

Leahy Patent Transparency And Improvements Act (0)

Exelixis (0)

Novartis (0)

Request For Continued Examination (RCE) (0)

Patent Trial And Appeal Board (PTAB) (0)

Patent Subject Matter Eligibility (0)

Attributable Owner (0)

Real Party In Interest (0)

Ultimate Parent Entity (0)

Clones (0)

Dolly (0)

Europe (0)

France (0)

Representation (0)

UK (0)

biased judge (0)

partiality (0)

Arbitration (0)

EU competition law (0)

License agreeement (0)

Court of Appeals (0)

Federal Circuit (0)

US (0)

Ajinomoto (0)

Conservatory measures (0)

Counterfeit (0)

Italy (0)

Michele di Sciuva (0)

Richard Vary (0)

renewal fees (0)

Benoit Battistelli (0)

Netherlands (0)

Wouter Pors (0)

Business Europe (0)

Eurochambres (0)

Piercing the corporate veil (0)

copyright (0)

Ctm (0)

government (0)

ohim (0)

trade mark (0)

Beijing Treaty (0)

EC (0)

intergovernmental organisations (0)

Marrakesh Treaty (0)

trade (0)

WIPO (0)

WTO (0)

Spain (0)

Examination report (0)

UKIPO (0)

EU (0)

Canada (0)

international treaties (0)

Japan (0)

judicial review (0)

mediation (0)

district court (0)

term (0)

USA (0)

Australia (0)

ECHR (0)

experts (0)

hot-tubbing (0)

insight (0)

IPEC (0)

Ireland (0)

judges (0)

judiciary (0)

procedure (0)

competition (0)

innovation (0)

EPC 2000 (0)

swiss-style (0)

assignment (0)

employee (0)

priority (0)

title (0)

licensing (0)

transactions (0)

valuation (0)

amino acids (0)

antibodies (0)

antibody (0)

biologic (0)

biosimilar (0)

BPCIA (0)

protein (0)

AIA (0)

amendment (0)

construction (0)

EPC (0)

Markman (0)

post-grant (0)

PTAB (0)

USPTO (0)

genes (0)

section 101 (0)

software (0)

technical (0)

Patent Quality (0)

European Commission (0)

Competition law (0)

Akamai (0)

Direct Infringement (0)

Limelight (0)

Good faith (0)

Finland (0)

Czech Republic (0)

Slovakia (0)

Catalonia (0)

independence (0)

Russia (0)

Scotland (0)

Unjustified threats (0)

Kyle Bass (0)

Damages (0)

Interim Injunction (0)

EPLIT (0)

Andorra (0)

SMEs (0)

IP Ownership (0)

European (0)

Antitrust (0)

Industrial Property (0)

Rules of procedure (0)

Protective Letter (0)

Productivity Commission (0)

Quizz (0)

fair basis (0)

GlaxoSmithKline (0)

Omnibus (0)

Reckitt (0)

Second Medical Use (0)

floating charge (0)

pledge (0)

security interests (0)

computer programming (0)

gaming machine (0)

IP Australia (0)

RPL Central (0)

Court Fees (0)

Actavis (0)

Apotex (0)

exclusive licence (0)

orion (0)

Patents Act 1990 (0)

Biosimilars (0)

AIPPI (0)

co-inventorship (0)

Full Federal Court of Australia (0)

inventive concept (0)

inventorship (0)

PCT application (0)

provisional application (0)

draft legislation (0)

extension of time (0)

Quiz (0)

business method (0)

evergreening (0)

fees (0)

IP Arrangements (0)

Patents Act (0)

pay-for-delay (0)

Federal Court of Australia (0)

Generic Health (0)

Isabelle (0)

post-tax loss (0)

pre-tax loss (0)

substitutability (0)

Britax (0)

Coretell (0)

date of patent (0)

filing (0)

grant (0)

innovation patents (0)

Mud (0)

exploit (0)

Lyrica (0)

offer (0)

PBS listing (0)

Pharmaceutical Benefits Scheme (0)

pregabalin (0)

Warner-Lambert (0)

Estonia (0)

law reform (0)

objects clause (0)

Antonio Campinos (0)

Analytics (0)

IPR (0)

Boards of Appeal (0)

quality (0)

efficiency (0)

vision (0)

judicial independence (0)

Administrative Council (0)

trust (0)

clinical trials (0)

76A (0)

innovation patent (0)

Battistelli (0)

human rights (0)

freedom of contract (0)

technology transfer (0)

University inventions (0)

Generics (0)

passing-off (0)

Competition Act (0)

Licence (0)

reform (0)

trade practices (0)

Medical Devices (0)

Artificial Intelligence (0)

Machine Learning (0)

plant variety (0)

Dependent claims; search; prosecution (0)

machine (0)

Switzerland (0)

repeal (0)

Tenofovir (0)

Confidential (0)

enablement (0)

book review (0)

visser (0)

Ethiopia (0)

Food (0)

Biogen insufficiency (0)

Classical insufficiency (0)

European Patent Convention (0)

European Patent Office (0)

Kimberly-Clark (0)

plausibility (0)

undue burden (0)

Bundespatentgericht (0)

District Court of The Hague (0)

invalidation (0)

preliminary injunctions (0)

A Practitioner's guide to Supplementary Protection Certificates in Europe (0)

Alexa von Uexküll (0)

Oswin Ridderbusch (0)

examination (0)

flexible timing (0)

speed (0)

Google (0)

non-technical features (0)

patent application (0)

trade secrets (0)

Board of Appeal (0)

Haar (0)

Munich (0)

Traveling Circus (0)

financial sustainability (0)

Cyprus (0)

International Preliminary Examination (0)

Re-establishment of rights (0)

implied licence (0)

Menck (0)

unfair competition (0)

FRAND licences (0)

nonbviousness (0)

surgical devices (0)

EQE (0)

181 patent (0)

dosage patent (0)

obviousness (0)

PACTE law (0)

RPBA (0)

patent litigation (0)

saisie contrefaçon (0)

sub-ranges (0)

Problem Inventions (0)

Ericsson (0)

TCL Communication Technology Holdings Ltd. (0)

abridged form of decision (0)

Art. 15(9) RPBA (0)

Rules of Procedure of the Boards of Appeal (RPBA) (0)

mechanical patent (0)

Alternatives (0)

Enhanced Damages (0)

Willful Blindness (0)

epi (0)

SSOs (0)

Ghent Business Court (0)

opposition fee (0)

Hugo Meinders (0)

Rules of Procedure of the Boards of Appeal (0)

Global Patent Strategy (0)

Patent Strategy (0)

patentable (0)

Closest Prior Art (0)

Problem-Solution-Approach (0)

user-friendly (0)

ezetimibe (0)

ezetimibe-simvastatine (0)

reformatio in peius (0)

Eli Lilly (0)

Business model (0)

Patent protection (0)

Value proposition (0)

anti-suit injunction (0)

EPC 138/3 (0)

ETSI (0)

European Telecommunications Standards Institute (0)

Huawei (0)

je t'aime moi non plus (0)

Unwired Planet (0)

trademarks (0)

Board op Appeal (0)

ViCo (0)

videoconferencing (0)

AASI (0)

TRUVADA (0)

Hutchinson (0)

SPC Waiver Regulation (0)

Standard-Setting Organisations (SSOs). (0)

Democracy (0)

novelty assessment (0)

sufficiency of disclosure (0)

Amgen’s Repatha (0)

Sanofi’s Praluent (0)

Transparency of Declarations (0)

Comparable licenses approach (0)

Conversant vs ZTE/Huawei (0)

Philips vs TCL (0)

Top Down Approach (0)

TQ Delta v ZyXel or Optis v Apple (0)

Unwired Planet vs Huawei (0)

New Normal (0)

Nemo Iudex (0)

Warning letter (0)

Contributory infringement (0)

International Law Talk (0)

Patent settlements (0)

Patent term extension (0)

Patent linkage (0)

PRC patent (0)

Investment Treaty Arbitration (0)

Patent breaking (0)

TRIPS COVID-19 Waiver (0)

Delaware District Court (0)

Hatch-Waxman Act (0)

U.S. Court of Appeals (0)

Inventor (0)

Amicus Brief (0)

SUEPO (0)

Enlarged Board of Appeal (0)

oral proceedings (0)

video conference (0)

Food and Drug Administration (0)

United States Patent and Trademark Office (0)

Foundation for a Smoke-Free World (0)

Smoking (0)

Tobacco (0)

Tobacco harm-reduction patents (0)

Patent Trial and Appeal Board (0)

Post Grant Review (PGR) (0)

Alternative dispute resolution (ADR) (0)

Federal Trade Commission (0)

organization (0)

limitation period (0)

refund (0)

licensing negotiation process (0)

predictability (0)

predictability of domestic litigations (0)

transparency (0)

Exclusive patent license (0)

Medicine (0)

International Organization for Standardization (0)

Standard Setting Organizations (0)

Statistics (0)

History (0)

ILOAT (0)

government policy (0)

top 3 (0)

common interest (0)

communication (0)

buildings (0)

EUIPO (0)

code of conduct (0)

2023 edition (0)

Annotated European Patent Convention (0)

unity of invention (0)

5G (0)

RNA Law (0)

Arkyne (0)

Florence Butin (0)

Local division UPC The Hague (0)

Plant-e (0)

Amazon (0)

multimedia (0)

reforms (0)

Beat Weibel (0)

IPQC (0)

call for papers (0)

London (0)

PhD (0)

CMS UPC (0)

Legal Team functionality (0)

CMS functionalities (0)

Sir Robin Jacob (0)

procedural language (0)

devolutive effect (0)

top ten 2023 (0)

Bristows (0)

Mathys & Squire (0)

divisional (0)

IBEC (0)

Neale Richmond (0)

North Macedonia (0)

Milan (0)

UPC central division (0)

European Parliament (0)

NGT (0)

plants (0)

Alexander Ramsay (0)

Irish referendum (0)

10xGenomics (0)

NanoString (0)

UPC Court of Appeal (0)

fingolimod (0)

Translators (0)

AR (0)

Metaverse (0)

Technology (0)

VR (0)

XR (0)

Manual IP (0)

MIP (0)

sustainability (0)

welfare (0)

Andean Community (0)

Bolivia (0)

description (0)

Christmas (0)

European Union; FRAND (0)

SEP (0)

use claim (0)

bad faith (0)

claim interpretation (0)

G1/24 (0)

Bolar Exception (0)

appellate review (0)

UK Supreme Court (0)

dimethyl fumarate (0)

presumption of validity (0)

best method requirement (0)

contact rights (0)

BRAZIL (0)

LINKAGE (0)

Colombia (0)

expedited proceedings (0)

FPC (0)

EU-MERCOSUR (0)

Contributor

Thorsten Bausch (89)

Thomas Musmann (71)

Jochen Buehling (40)

Markus Lenssen (12)

Kluwer Patent blogger (9)

Anja Lunze (8)

Volker Tillmann (7)

Christian Buchholz (6)

Clemens Rübel (6)

Hetti Hilge (6)

Dominik Scheible (4)

Henrik Timmann (4)

Axel T. Esser (3)

Birgit Kramer (3)

Daniel Graetsch (3)

Eike Schaper (3)

H. Jeremias V. Wollschlaeger (3)

Roland Schieren (3)

Alexa von Uexküll (2)

Enrico Bonadio (2)

Jan Zillies (2)

Philipp Widera (2)

Rüdiger Pansch (2)

Stephan von Petersdorff-Campen (2)

Bernward Zollner (1)

Brian Cordery (1)

Dr. Alex Frank (1)

Dr. Lisa Rieth (1)

Dr. Narayan Sircar (1)

Fabian Hötzel (1)

Felix Briza (1)

Friedrich Felix Jacob (1)

Jan Carl Zilles (1)

Kaspar Feldmeier (1)

Katrin Gutsmiedl (1)

Kluwer Patent Blog (1)

Korbinian Kopf (1)

Liat Sanz Martinez (1)

Martin Hohgardt (1)

Matthieu Dhenne (1)

Michaela Ring (1)

Mike Gruber (1)

Nadja Muncke (1)

Niels Hölder (1)

Richard Gillespie (1)

Simon Klopschinski (1)

Simon Michels (1)

Thomas Becher (1)

Tilman Müller-Stoy (1)

Tobias Hahn (1)

Bruno Weil (0)

Mark Einerhand (0)

Krystyna Szczepanowska-Kozlowska (0)

Peter Burgers (0)

Lars de Haas (0)

Ivan Marinov (0)

Mark van Gardingen (0)

Sam Tuxford (0)

Bart van Weezenbeek (0)

Miquel Montañá (0)

Peter-Ulrik Plesner (0)

Robert Burrows (0)

Florence Verhoestraete (0)

Ferry van Looijengoed (0)

Daan de Lange (0)

Klaas de Vries (0)

Marjanka Vermunt (0)

Christian Gassauer-Fleissner (0)

Iustina Grigordiadis (0)

Rik Lambers (0)

Pierre Véron (0)

Daniela Ampollini (0)

Erik Visscher (0)

Ruprecht Hermans (0)

Kristof Roox (0)

Derk Visser (0)

Anders Valentin (0)

Olivier Moussa (0)

Kaja Veel Midtbø (0)

Eleni Lappa (0)

Simon Holzer (0)

Giovanni Gozzo (0)

Maja Bogataj Jančič (0)

Mindaugas Kiskis (0)

Gustav Bacher (0)

Richard Ebbink (0)

Andri Hess (0)

Lars Erik Steinkjer (0)

Andrew Sharples (0)

Robert Fitt (0)

Courtenay C. Brinckerhoff (0)

Robert Lundie Smith (0)

Emmanuel Gougé (0)

Shane O'Brien (0)

Matthew Blaseby (0)

Theofanis Salatas (0)

Tamara Elmore (0)

Johanna Lilja (0)

Laurence Brown (0)

Patricia Cappuyns (0)

Claire Purkiss (0)

Katie Rooth (0)

Matthew Raynor (0)

David Nilsson (0)

Leigh-Anne Thomas (0)

Gabriel Cuonzo (0)

Manuel Wegrostek (0)

Amy Cullen (0)

Pieter Callens (0)

Benjamin Bai (0)

Gregory Bacon (0)

Isabelle Romet (0)

Mathilda Nordmark (0)

Luke McDonagh (0)

Dr. Ingve Björn Stjerna (0)

Begoña González Otero (0)

Anton Polikarpov (0)

Jan Lindberg (0)

Gerben Hartman (0)

Rien Broekstra (0)

Audrey Nemeth (0)

Daniel Byrne (0)

Adam Flint (0)

Alexandre L. Dias Pereira (0)

Jan Pot (0)

Claire Phipps-Jones (0)

Peter Ling (0)

Paul Marcelis (0)

Thomas Long (0)

Edward L. Puzzo (0)

Mark Engstrom (0)

Jody Coultas (0)

Peter Reap (0)

Åse Røynestad Konsmo (0)

Valerie Eder (0)

Cheryl Beise (0)

Aida Tohala (0)

Brandi O. Brown (0)

Beatriz San Martin (0)

Russell Beck (0)

Greg Hammond (0)

Thomas Hendicott (0)

Krišjānis Bušs (0)

Jan-Diederik Lindemans (0)

Devika Agarwal (0)

Gaëlle Béquet (0)

newgenblog (0)

Beatrice Nybert (0)

Lodewijk Pessers (0)

John Collins (0)

Verena von Bomhard (0)

Patrick Harrison (0)

Vanessa Rieu (0)

Dominic Adair (0)

Alona Kiriak (0)

Allen Dixon (0)

Maria Kendrick (0)

Yuqing Feng (0)

Pierre Heuzé (0)

Linda O'Brien (0)

Frits Michiels (0)

Hui Zhang (0)

Inga Lukauskienė (0)

Adrian Chew (0)

Richard Li (0)

Elisabeth C. Pope (0)

Jiao Yuxin (0)

Jurgen Figys (0)

Yin Li (0)

Laura von Herzen (0)

Nicolaj Bording (0)

James Yang (0)

Annsley Ward (0)

Adrian Crespo (0)

Rachel Mumby (0)

Nigel Swycher (0)

Brian Slater (0)

Emma Muncey (0)

Eszter Szakács (0)

Samuel Adams (0)

Christos Theodoulou (0)

Gregory Sephton (0)

Alan Johnson (0)

Benjamin May (0)

Francois Pochart (0)

Alexander de Leeuw (0)

Laura Reynolds (0)

Boris Malakhov (0)

Sara Moran (0)

Craig Lumb (0)

Joseph Arshawsky (0)

Rebecca Kahn (0)

Laurence Lai (0)

Linda Panszczyk (0)

Nicholas Round (0)

Brian Craig (0)

Arnie Clarke (0)

Harold S. Berman (0)

Ilarion Tomarov (0)

George Basharis (0)

Oswin Ridderbusch (0)

Bart van Wezenbeek (0)

Wouter Pors (0)

Sam Jones (0)

Filko Prugo (0)

Joshua Price (0)

Andrea Sommer (0)

Joost Duijm (0)

Scott King (0)

Boukje van der Maazen (0)

Paul Reiter (0)

Michael Vallance (0)

Matt Pavich (0)

Matthew Rizzolo (0)

Grégoire Desrousseaux (0)

Alex Calver (0)

Nadine Bleach (0)

Selin Sinem Erciyas (0)

Barbara Abegg (0)

Kate O’Sullivan (0)

Leon Li (0)

Aysel Korkmaz Yatkın (0)

Selina Badiani (0)

James Prankerd Smith (0)

Gemma Wooden (0)

Binxin Li (0)

Harriet Crawford (0)

Nidhisha Garg (0)

Vaishali Mittal (0)

Ben Millson (0)

Jonathan Ross (0)

Charlotte Jacobsen (0)

Emma Irwin (0)

Thomas K. Lauletta (0)

Matteo Mariano (0)

Roya Ghafele (0)

David Yucht (0)

Kathrin Füchsle (0)

Roberto A. Jacchia (0)

Elizabeth McAuliffe (0)

Bashar H. Malkawi (0)

Alex Latham (0)

Nicole D. Prysby (0)

Pamela C. Maloney (0)

Sheri A. Wattles-Miller (0)

Richard Mair (0)

Jiří Slavík (0)

João Pedro Quintais (0)

Luca Falciola (0)

Olivia Henry (0)

Lisa L. Mueller (0)

Roberto Castro de Figueiredo (0)

Magnus Dahlman (0)

Somto Kizor-Akaraiwe (0)

António Magalhães Cardoso (0)

Neemesh Chheda (0)

Ananta Saxena (0)

Lena Hornkohl (0)

Radhi Shah (0)

Naho Ebata (0)

Nick Michelmore (0)

Kevin M. Finson (0)

Florence Plisner (0)

Sophie Britton (0)

Kluwer IP Reporter (0)

Chloe Dickson (0)

Richard Aarons (0)

William White (0)

Natalie Shoolman (0)

Mami Hino (0)

Christopher Dumont (0)

Gabriel Di Blasi (0)

Rob Rodrigues (0)

David Hemming (0)

Eden Winlow (0)

Matthew Hersh (0)

Nina Ferara (0)

Joachim Henkel (0)

Luke Maunder (0)

Callum Beamish (0)

Kirill Osipov (0)

Karlo Tinoco (0)

Lucie Fortune (0)

Kameshwaris Sridhar (0)

Alina Trapova (0)

Ivo Emanuilov (0)

Myles Jelf (0)

Rebekka Thomas (0)

Katie Cambrook (0)

Richard Pinckney (0)

Danilo Ruggero Di Bella (0)

Anne Marie Verschuur (0)

Adam Lacy (0)

Louis Bidaine (0)

Milly Wickson (0)

Liz Cohen (0)

Rebecca Daramola (0)

Charlie French (0)

Francion Brooks (0)

Jonathan Santman (0)

Jasmijn de Groot (0)

Hannah Rigby (0)

Naomi Hazenberg (0)

Hafsa Babar (0)

Dr. Malte Köllner (0)

Dr. Carlota Vergas Romero (0)

James Boon (0)

Laura Durán (0)

Eveline Lots (0)

Malin Malm Waerme (0)

Nischay Mall (0)

Prof. Dr. Aloys Hüttermann (0)

Joana Piriquito Santos (0)

Georgii Stoiko (0)

Christophe Arfan, Associate and UPC Representative (0)

Georgii Stoiko, Patent Attorney (0)

Naoise Gaffney (0)

Ewan MacAulay (0)

Date

From

To

End date must be later than the start date.

Search Results for:

331 results available

331 - 331 of 331 results

About Kluwer Patent Blog
Contact Us

Wolters Kluwer: IP Law
Wolters Kluwer: X
YouTube

Editorial Policy & Guidelines
Privacy Policy and Use of Cookies
User Agreement and Disclaimer